Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Pison C, Shah PL, Slebos DJ, Ninane V, et al. Respir Res 2021;22:62.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pison C, Shah PL, Slebos DJ, Ninane V, et al. Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Respir Res 2021;22:62.
PMID: 33608007